Background and purpose
Dose Painting (DP) in radiotherapy is a strategy to account for the tumor microstructural heterogeneity. This study evaluated a DP approach in carbon ion radiotherapy (CIRT), using cell count estimates derived from diffusion-weighted magnetic resonance imaging (DWI).
Materials and methods
Thirty-seven large sacral chordoma (SC) patients were analysed. Voxel-wise cell count was estimated from DWI using a published microstructural model. A Poisson-based tumor control probability (TCP) model, fitted on 27 patients, guided DP optimization in a research version of RayStation 2024A. The approach was tested on 10 patients, comparing uniform-dose plans against two strategies: dose redistribution (DR), which maintained the mean gross tumor volume (GTV) dose, and dose escalation (DE), which allowed a 3 % increase. Plan evaluation on targets and organs at risk (OARs) included dose-volume histogram metrics (D95%, D50%, D1%) and dose-averaged linear energy transfer (LETd)-volume histogram metrics (L98%, L50%, L1%) to assess clinical acceptability. TCP gain quantified the benefit of biologically targeted strategies. TCP uncertainty was evaluated by propagating the microstructural model’s errors to generate best- and worst-case cell count maps.
Results
DE and DR plans met clinical acceptability criteria. DE increased TCP from 75.5 ± 5.6 % to 83.3 ± 3.9 % (p < 0.001), with −3 to +5 percentage points variation under uncertainty. DR plans showed a TCP gain of 1.8 ± 1.0 percentage points. No significant dose or LETd increase was observed in OARs, while DE plans showed a lower L98% in GTV.
Conclusions
Dose painting based on microstructural modelling in CIRT showed potential to improve TCP while sparing OARs.
扫码关注我们
求助内容:
应助结果提醒方式:
